Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Drug Eluting & Conventional Trans-arterial Chemo-embolization in Treatment of Primary Hepatic Cell Carcinoma

NCT04048317 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04048317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04048317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Drug Eluting & Conventional Trans-arterial Chemo-embolization in Treatment of Primary Hepatic Cell Carcinoma
Lead sponsor
Assiut University
Phase
Phase 1
Overall status
Unknown status
Start date
September 1, 2019
Completion date
December 1, 2020
Enrollment
75 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic cell carcinoma